Because mouse model studies have correlated protection to the capacity of Mtb-specific CD4+ T cells to migrate to lung tissue (20, 21) and engage infected antigen-presenting cells (22), a key strategic focus in TB vaccine research is to overcome this delay by eliciting early recruitment of T cells into the infected lung for effective control of Mtb (22, 23). This evidence concerns the gene CD4 and tuberculosis.